Alcohol as a Novel Trigger for Cannabis Hyperemesis Syndrome
Alcohol cannabis hyperemesis trigger is emerging as a novel factor in cannabis hyperemesis syndrome (CHS). This condition affects chronic cannabis users with cyclic nausea and vomiting. Understanding alcohol's role may improve clinical counseling and…
Cannabinoid Clinical Trials: CBD and Cortical Excitability Insights
This clinical trial investigates CBD antiseizure pharmacokinetic interaction and its effects on cortical excitability. Results indicate CBD alone does not alter cortical excitability in healthy men. The findings highlight the importance of drug…
Cannabidiol & Cortical Excitability: Clinical Trial Evidence
The cannabidiol cortical excitability clinical trial evaluated CBD's direct effects on brain excitability in healthy males. Results showed no significant reduction in cortical excitability, highlighting the importance of drug interactions. This trial…
Endocannabinoid System Research: CBD & Cortical Excitability
In a controlled crossover trial, cannabidiol lacks direct effect on cortical excitability compared to placebo. This suggests CBD’s anti-seizure benefits depend on interactions with medications like clobazam. Clinicians should consider this when…